Skip to main content

IDEAYA Biosciences, Inc.

IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001676725

In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.

Members of Congress who traded IDYA

No member of Congress has reported a trade in IDEAYA Biosciences, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.